A randomized phase II evaluation of bryostatin-1 (NSC #339555) in recurrent or persistent platinum-sensitive ovarian cancer: A Gynecologic Oncology Group Study

Deborah K. Armstrong, John A. Blessing, Katherine Y. Look, Russell Schilder, Evelyn R. Nunez

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A randomized phase II evaluation of bryostatin-1 (NSC #339555) in recurrent or persistent platinum-sensitive ovarian cancer: A Gynecologic Oncology Group Study'. Together they form a unique fingerprint.

Medicine & Life Sciences